Viral Hemorrhagic Fever (VHF): Causes, Pathophysiology, and Types

A traveler returns from West Africa with a fever, muscle pain, and a headache. For three days it looks like malaria. Then the gums begin to bleed, the blood pressure falls, and small hemorrhages appear under the skin.

This is the moment that separates viral hemorrhagic fever from the hundred other febrile illnesses it first imitates. The bleeding is not the start of the disease. It is the visible end stage of something the virus began days earlier, deep in the lining of the blood vessels.

Viral hemorrhagic fever (VHF) is not one disease. It is a shared clinical syndrome produced by several unrelated families of RNA viruses. What links them is not their genetics but what they do to the body: they damage the vascular system so severely that the blood loses its ability to stay inside the vessels and clot normally. The result is fever combined with bleeding, leaking capillaries, low blood pressure, and in the worst cases multi-organ failure and shock.

The severity ranges widely. Some infections stay mild or even unnoticed. Others, such as Ebola and Marburg disease, are among the most lethal infections known to medicine. Many of the causative agents are handled only in Biosafety Level 4 (BSL-4) laboratories, the highest containment level, because they are dangerous, easily transmitted, and have no reliable cure.

Figure: viral hemorrhagic fever

Every VHF virus survives in nature inside a reservoir host, an animal or arthropod that carries the virus without dying from it. Depending on the virus, that reservoir is a rodent, a bat, a tick, or a mosquito. Humans are accidental, dead-end hosts for most of them.

Infection happens when a person contacts the reservoir directly (rodent urine, a bat cave), is bitten by an infected vector (a tick carrying Crimean-Congo hemorrhagic fever), or contacts the body fluids of another infected person. For the filoviruses (Ebola and Marburg), fruit bats are the strongly suspected reservoir, though the exact chain of natural transmission is still not fully proven.

Why viral hemorrhagic fevers cause bleeding

Four unrelated virus families converge on one syndrome because they attack the same target: the endothelium, the single layer of cells lining every blood vessel. Understanding this one mechanism explains almost every sign of VHF.

A healthy endothelium does two jobs at once. It keeps fluid and blood cells inside the vessel, and it keeps blood in a balanced state, neither clotting spontaneously nor bleeding freely. VHF viruses break both jobs, through two connected routes.

1. Direct and immune-mediated endothelial damage. Some VHF viruses infect endothelial cells directly. Others damage them indirectly by triggering an overwhelming immune response. Either way, the vessel lining becomes leaky. Plasma escapes into the tissues. This is why patients develop low blood pressure, swelling, and hemoconcentration (the blood becomes thicker as fluid leaves it). In dengue, this plasma leak, not bleeding itself, is the main driver of shock.

2. Disruption of clotting (coagulopathy). As the syndrome progresses, the clotting system is consumed faster than the body can replace it. Platelets fall (thrombocytopenia). Clotting factors are used up. In severe cases this becomes disseminated intravascular coagulation (DIC): the body forms tiny clots throughout the circulation and, having exhausted its clotting supplies, can no longer stop bleeding anywhere. The patient bleeds and clots at the same time.

Layered on top of both routes is a cytokine storm. The infected body releases a flood of inflammatory signals that increase vascular permeability further and worsen the shock. This runaway inflammation, more than the virus killing cells directly, is what makes the sickest patients deteriorate so fast.

Putting it together as a sequence:

virus infects and damages endothelium → capillaries leak plasma → blood pressure falls → clotting system is consumed (thrombocytopenia, DIC) → widespread bleeding → shock and organ failure

The bleeding a clinician finally sees at the bedside is the last step in this chain, not the first. That is why VHF looks like an ordinary fever for its first few days and becomes unmistakable only once the vascular damage is advanced.

Etiology

True viral hemorrhagic fevers are caused by four groups of enveloped RNA viruses. The table below lists the important human pathogens in each. Note two common exam traps flagged after the table.

Two corrections worth knowing. The old family "Bunyaviridae" no longer exists as a single family. In 2017 it was reorganized into the order Bunyavirales, and its former genera became separate families (Hantaviridae, Nairoviridae, Phenuiviridae, Peribunyaviridae). Older textbooks still use the old name.

Not all famous flaviviruses cause VHF. Japanese encephalitis virus and Zika virus are flaviviruses, but they are neurological and congenital pathogens, not hemorrhagic ones. They do not belong on a list of VHF causes despite being close relatives of dengue and yellow fever. (For Japanese encephalitis, see the dedicated article on Japanese encephalitis.) Lymphocytic choriomeningitis virus (LCMV) and Hendra virus are sometimes listed loosely under this heading, but LCMV mainly causes aseptic meningitis and congenital infection, and Hendra is a respiratory and encephalitic henipavirus. Neither is a classic hemorrhagic fever.

Common properties of viruses causing VHFs

• All are enveloped RNA viruses. Being enveloped matters clinically: it makes them fragile in the environment and readily destroyed by soap, detergents, and standard disinfectants, which is central to outbreak control.
• Each has a natural reservoir in an animal or arthropod host, not humans. Humans are usually accidental hosts.
• Human infection begins with contact with the reservoir or vector. For several of these viruses, once a human is infected, person-to-person spread through body fluids can follow.
• Each is geographically restricted to where its reservoir or vector lives. This is why travel history is a critical diagnostic clue.
• There is no reliable cure for most VHFs. Care is largely supportive. The important exceptions: yellow fever and Argentine hemorrhagic fever have vaccines, ribavirin has some benefit in Lassa fever and CCHF, and specific therapies and vaccines now exist for Ebola. Read more about Ebola virus disease.

Diseases caused by these viruses

• Dengue hemorrhagic fever (DHF)
• Marburg hemorrhagic fever
• Ebola hemorrhagic fever
• Lassa fever
• Crimean-Congo hemorrhagic fever (CCHF)
• Kyasanur Forest disease (KFD)
• Lujo hemorrhagic fever (LUHF)
• Omsk hemorrhagic fever (OHF)
• Rift Valley fever (RVF)
• Chapare hemorrhagic fever (CHHF)

How the major viral hemorrhagic fevers differ

Students often lump all VHFs together. In practice, three features separate them: how they spread, where they occur, and whether they pass person to person. That last column decides whether a patient needs strict isolation.

The single most useful line to remember: the person-to-person VHFs (Ebola, Marburg, Lassa, CCHF) are the ones that cause hospital outbreaks and demand barrier nursing. The vector-borne ones (dengue, yellow fever, RVF) do not spread from patient to patient, so an infected patient is not a direct danger to staff through casual contact.

Prevention and prophylaxis

Because most viral hemorrhagic fevers have no cure, prevention carries most of the clinical weight. What works depends entirely on how the virus reaches humans, which is why the transmission route is the organizing principle below.

Where a vaccine exists, use it. Vaccines are available for yellow fever, Argentine hemorrhagic fever (Junín virus), and Ebola. The yellow fever vaccine in particular is highly effective and is required for travel to some endemic countries. For most other VHFs, no licensed vaccine is available, so prevention rests on avoiding exposure.

For the rodent-borne viruses (Lassa, hantavirus, some arenaviruses), the goal is to reduce contact with rodents and their excreta. This means controlling rodent populations, keeping rodents out of homes and food stores, and cleaning nests and droppings safely rather than sweeping or vacuuming them, which can aerosolize infectious particles.

For the vector-borne viruses (dengue, yellow fever, Rift Valley fever, Kyasanur Forest disease, CCHF), the goal is to avoid bites from the mosquito or tick that transmits them. This means using insect repellent, wearing clothing that covers the skin, sleeping under bed nets, using window screens, and reducing vector breeding sites such as standing water for mosquitoes.

For the person-to-person viruses (Ebola, Marburg, Lassa, CCHF), the goal is to interrupt transmission through body fluids, which is where hospital outbreaks begin. Infected patients must be isolated. Healthcare workers must wear protective clothing and follow barrier nursing. Needles, thermometers, and other equipment must be used, disinfected, and disposed of correctly. Safe burial practices also matter, because the body of a person who has died of Ebola remains highly infectious.

Because these viruses are enveloped, they are readily inactivated by soap, detergents, and standard disinfectants. Simple, consistent infection control is therefore one of the most powerful tools available against them.

How to Remember

Tie each family to its reservoir, because the reservoir is what you actually get asked and what drives prevention:

• Arenaviridae → think arena = sand → sandy rodent burrows → rodents (Lassa). Arenaviruses even look grainy/sandy under EM (the name's origin).
• Filoviridae → filo = thread → the long threadlike Ebola/Marburg virions → bats.
• Bunyavirales → the big mixed bag → ticks, rodents, mosquitoes all appear here (CCHF, Hanta, RVF).
• Flaviviridae → flavus = yellow → yellow fever → mosquitoes.

Which ones spread person to person (the isolation four): "LM & CE" → Lassa, Marburg, CCHF, Ebola. If you can name these four, you can answer almost every "which VHF needs barrier nursing" question. The rest are vector-borne and do not.

The mechanism in five words: leak, then clot, then bleed. Endothelium leaks plasma → clotting factors get consumed → patient bleeds. If you can say that sequence, you understand VHF better than a list of family names would ever show.

Key exam facts

Where Students Get Confused

"Isn't VHF one specific disease?" No. It is a syndrome. Ebola, dengue, and Lassa are all "VHFs," but they are unrelated viruses that happen to produce the same final picture of fever plus bleeding. Treat "VHF" like "pneumonia": a pattern with many causes, not a single organism.

"The bleeding is what kills the patient." Usually not directly. In most VHFs the lethal problem is shock from plasma leak and vascular collapse, plus multi-organ failure. Visible bleeding is a marker of how severe the vascular and clotting damage has become, not always the direct cause of death. In dengue specifically, plasma leakage causing shock is the danger, and many severe cases bleed relatively little.

"Are Japanese encephalitis and Zika VHFs? They're flaviviruses like dengue." No, and this is the most common trap on this topic. Same family, completely different disease. JEV causes brain inflammation; Zika causes congenital defects and neurological disease. Neither causes a bleeding syndrome. Family relationship does not equal clinical resemblance.

"All VHF patients need strict isolation." Only some. The person-to-person spreaders (Lassa, Marburg, CCHF, Ebola) require barrier nursing. A dengue or yellow fever patient cannot infect a nurse through contact, because those need a mosquito to complete transmission.

"Why can't we just treat them with antivirals?" For most, no specific antiviral exists. Ribavirin helps in Lassa and CCHF; Ebola now has specific therapies and a vaccine. For the rest, treatment is supportive: fluids, blood products, and organ support. This is why prevention (vectors, rodents, isolation) carries so much weight.

References

1. Fhogartaigh, C. N., & Aarons, E. (2015). Viral haemorrhagic fever. Clinical Medicine (London, England), 15(1), 61–66. https://doi.org/10.7861/clinmedicine.15-1-61
2. Pigott, D. C. (2005). Hemorrhagic fever viruses. Critical Care Clinics, 21(4), 765–783. https://doi.org/10.1016/j.ccc.2005.06.007
3. World Health Organization. (2024). Ebola disease and Lassa fever fact sheets. World Health Organization. https://www.who.int/health-topics/haemorrhagic-fevers
4. Centers for Disease Control and Prevention. (2024). Viral hemorrhagic fevers (VHFs). National Center for Emerging and Zoonotic Infectious Diseases. https://www.cdc.gov/viral-hemorrhagic-fevers/
5. Kuhn, J. H., et al. (2020). 2020 taxonomic update for the order Bunyavirales. Archives of Virology, 165, 3023–3072. https://doi.org/10.1007/s00705-020-04731-2